当前位置:首页 - 行情中心 - 益方生物-U(688382) - 财务分析

益方生物-U

(688382)

  

流通市值:97.89亿  总市值:97.89亿
流通股本:5.80亿   总股本:5.80亿

益方生物-U(688382)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-0.44亿元,每股收益-0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益149580.96万元,未分配利润-290615.87万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产160114.27万元,负债10533.30万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入42,542,363.9137,289,660.9630,893,466.919,163,847.37
营业总成本85,655,003.18353,562,227.75205,986,997.9131,684,739.5
其他经营收益
营业利润-44,259,262.21-316,623,274.68-181,245,999.11-119,432,479.85
利润总额-44,259,262.21-316,626,274.68-181,245,999.11-119,432,479.85
净利润-44,367,216.91-316,865,800.68-181,385,152.31-119,432,479.85
每股收益
其他综合收益-1,203,735.61-506,075.02-559,520.77-463,965.38
综合收益总额-45,570,952.52-317,371,875.7-181,944,673.08-119,896,445.23
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,546,402,911.911,651,236,597.251,714,499,837.051,759,896,254.06
非流动资产:
非流动资产合计54,739,75452,609,995.9949,967,399.7153,071,913.5
资产总计1,601,142,665.911,703,846,593.241,764,467,236.761,812,968,167.56
流动负债:
流动负债合计89,079,512.3148,902,915.0880,564,360.5375,955,262.69
非流动负债:
非流动负债合计16,253,537.118,827,568.7118,478,349.6718,910,729.4
负债合计105,333,049.4167,730,483.7999,042,710.294,865,992.09
所有者权益(或股东权益):
归属于母公司股东权益合计1,495,809,616.511,536,116,109.451,665,424,526.561,718,102,175.47
股东权益合计1,495,809,616.511,536,116,109.451,665,424,526.561,718,102,175.47
负债和股东权益合计1,601,142,665.911,703,846,593.241,764,467,236.761,812,968,167.56
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计4,522,773.35125,882,277.8535,576,435.9523,715,927.08
经营活动现金流出小计147,151,634.04281,327,102.83195,632,819.88130,965,827.44
经营活动产生的现金流量净额-142,628,860.69-155,444,824.98-160,056,383.93-107,249,900.35
投资活动产生的现金流量:
投资活动现金流入小计567,779,525.11,281,109,699.59950,395,807.66212,084,099.81
投资活动现金流出小计749,221,819.251,307,437,951.941,032,758,133.13505,436,399.7
投资活动产生的现金流量净额-181,442,294.15-26,328,252.35-82,362,325.47-293,352,299.89
筹资活动产生的现金流量:
筹资活动现金流入小计-6,974,337.66,974,337.66,884,523.15
筹资活动现金流出小计13,128,416.7813,194,666.385,843,945.243,695,841.8
筹资活动产生的现金流量净额-13,128,416.78-6,220,328.781,130,392.363,188,681.35
汇率变动对现金及现金等价物的影响-1,211,496.6-2,833,438.79-2,492,032.99-905,461.13
现金及现金等价物净增加额-338,411,068.22-190,826,844.9-243,780,350.03-398,318,980.03
期末现金及现金等价物余额384,708,655.07723,119,723.29670,166,218.16515,627,588.16
补充资料:
现金及现金等价物的净增加额--190,826,844.9--398,318,980.03
最新报告期:2026-05-06
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华鑫证券吴景欢,胡博新-0.46-0.35-0.202026-05-06
中金公司宋歌,张琎,朱言音-0.52-0.33--2026-04-30
长城国瑞证券胡晨曦,魏钰琪-0.20-0.19-0.112026-04-22
长江证券刘长洪,彭英骐-0.35-0.31-0.252026-04-21
东方证券伍云飞,傅肖依-0.44-0.40-0.152026-04-17
TOP↑